ArticlePloS one2022

Use of CRISPR/Cas9 with homology-directed repair to silence the human topoisomerase IIα intron-19 5' splice site: Generation of etoposide resistance in human leukemia K562 cells.

Victor A Hernandez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.